Assignee profile:

Longeveron Inc.

City:

Miami, Florida

Country:

United States

Published Applications:

12

Last publication date:

2026-05-07

Patent Grants:

3

Last grant date:

2025-12-16

Top Inventors for applications by Longeveron Inc.

These are the the leading inventors for applications assigned to Longeveron Inc.:

Recent patent applications by Longeveron Inc.

Longeveron Inc. based in Miami, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-05-07
US20260124248A1
Human necessities

TREATMENT OF SEXUAL DYSFUNCTION AND IMPROVEMENT IN SEXUAL QUALITY OF LIFE

#2 | 2026-01-29
US20260027158A1
Human necessities

Methods of Using Human Mesenchymal Stem Cells to Effect Cellular and Humoral Immunity

#3 | 2026-01-15
US20260014205A1
Human necessities

MMP-14 OR TIMP POTENCY ASSAY FOR MESENCHYMAL STEM CELLS

#4 | 2026-01-08
US20260009787A1
Physics

MMP-14 POTENCY ASSAY FOR MESENCHYMAL STEM CELLS

#5 | 2024-10-24
US20240350551A1
Human necessities

TREATMENT OF AGING FRAILTY COMPRISING ADMINISTERING BONE MARROW DERIVED MESENCHYMAL STEM CELLS

#6 | 2024-10-24
US20240350549A1
Human necessities

Use of Mesenchymal Stem Cells in Treatment of Juvenile Hypoplastic Left Heart Syndrome

#7 | 2024-08-01
US20240252627A1
Human necessities

MESENCHYMAL STEM CELLS AS VACCINE ADJUVANTS AND METHODS FOR USING THE SAME

#8 | 2023-10-05
US20230310509A1
Human necessities

Treatment of Alzheimer's Disease with Allogeneic Mesenchymal Stem Cells

#9 | 2023-07-13
US20230221303A1
Physics

POTENCY ASSAY

#10 | 2020-04-30 ✅ Patent 12,496,316 granted on 2025-12-16
US20200129558A1
Human necessities

TREATMENT OF SEXUAL DYSFUNCTION AND IMPROVEMENT IN SEXUAL QUALITY OF LIFE

#11 | 2019-09-26 ✅ Patent 12,465,620 granted on 2025-11-11
US20190290698A1
Human necessities

Methods of Using Human Mesenchymal Stem Cells to Effect Cellular and Humoral Immunity

#12 | 2019-02-07 ✅ Patent 11,975,068 granted on 2024-05-07
US20190038742A1
Human necessities

Mesenchymal stem cells as vaccine adjuvants and methods for using the same

Also check out Longeveron Inc.'s (Miami, United States) applicant profile with 10 patent applications submitted.

AssigneeID:

339378 ⎘